Cleared Traditional

K970778 - LEAD CONTROL (WHOLE BLOOD) LEVELS 1

K970778 is the FDA 510(k) clearance for LEAD CONTROL (WHOLE BLOOD) LEVELS 1 by More Diagnostics. It is a Class 1 Chemistry device (product code JJX) cleared through the Traditional 510(k) pathway after a 44-day FDA review.

K970778 · More Diagnostics · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1997
Decision
44d
Days
Class 1
Risk

K970778 is an FDA 510(k) clearance for the LEAD CONTROL (WHOLE BLOOD) LEVELS 1,2,3,4. Classified as Single (specified) Analyte Controls (assayed And Unassayed) (product code JJX), Class I - General Controls.

Submitted by More Diagnostics (Los Osos, US). The FDA issued a Cleared decision on April 17, 1997 after a review of 44 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1660 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all More Diagnostics devices

Submission Details

510(k) Number K970778 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 04, 1997
Decision Date April 17, 1997
Days to Decision 44 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
44d faster than avg
Panel avg: 88d · This submission: 44d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code JJX Single (specified) Analyte Controls (assayed And Unassayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJX Single (specified) Analyte Controls (assayed And Unassayed)

All 371
Devices cleared under the same product code (JJX) and FDA review panel - the closest regulatory comparables to K970778.
WAKO NEFA LINEARITY SET
K973072 · Wako Chemicals USA, Inc. · Sep 1997
ROCHE HEMOGLOBIN A1C CONTROL N AND CONTROL P
K972721 · Roche Diagnostic Systems, Inc. · Aug 1997
LIFESCAN SURESTEP PRO GLUCOSE CONTROL/LINEARITY SOLUTIONS
K971014 · Lifescan, Inc. · Apr 1997
IMMULITE THYROID AUTOANTIBODY CONTROL MODULE
K971051 · Diagnostic Products Corp. · Apr 1997
THE ELECSYS CALCHECK PROGESTERONE
K970984 · Boehringer Mannheim Corp. · Apr 1997
ELECSYS CALCHECK CEA
K970452 · Boehringer Mannheim Corp. · Mar 1997